J. Goldman & CO LP Poseida Therapeutics, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $1.88 Million - $2.29 Million	-301,391 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.09 - $10.71 $701,130 - $1.06 Million	98,890 Added 48.83%	301,391 $2.2 Million
Q2 2021 Aug 16, 2021	BUY	$7.96 - $10.07 $1.61 Million - $2.04 Million	202,501 New	202,501 $2.03 Million

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.